# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-047802
Filing Date
2023-04-20
Accepted
2023-04-20 16:32:40
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | tm239007-7_424b3.htm | 424B3 | 4677633
2 | GRAPHIC | lg_adaptimmune-4c.jpg | GRAPHIC | 65407
3 | GRAPHIC | lg_tcr-4c.jpg | GRAPHIC | 20631
4 | GRAPHIC | lg_pipersandler-4c.jpg | GRAPHIC | 13231
| Complete submission text file | 0001104659-23-047802.txt |  | 4815759

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271145 | Film No.: 23833553
SIC: 2836 Biological Products, (No Diagnostic Substances)